387
edits
Changes
Created page with '{{Drugcombi | base = quetiapine | add = topiramate | info = * Quetiapine is principally metabolized by CYP3A4 to active and inactive metabolites. * Topiramate induces CYP3A4 an...'
{{Drugcombi
| base = quetiapine
| add = topiramate
| info =
* Quetiapine is principally metabolized by CYP3A4 to active and inactive metabolites.
* Topiramate induces CYP3A4 and is an inhibitor of CYP2C19.
* This combination of drugs may have possible synergistic effects. However, this combination will also have additive side effects. Dose adaptation will be recommended for this combination.
| start =
* Start topiramate according general dosing advice.
| cave =
* Caution is advised when topiramate is prescribed with other drugs that predispose patients to heat-related disorders, including carbonic anhydrase inhibitors and drugs with anticholinergic activity. <ref name="drugscom">
{{Drugscominteract|quetiapine-with-topiramate|quetiapine|topiramate}}</ref>
}}
| base = quetiapine
| add = topiramate
| info =
* Quetiapine is principally metabolized by CYP3A4 to active and inactive metabolites.
* Topiramate induces CYP3A4 and is an inhibitor of CYP2C19.
* This combination of drugs may have possible synergistic effects. However, this combination will also have additive side effects. Dose adaptation will be recommended for this combination.
| start =
* Start topiramate according general dosing advice.
| cave =
* Caution is advised when topiramate is prescribed with other drugs that predispose patients to heat-related disorders, including carbonic anhydrase inhibitors and drugs with anticholinergic activity. <ref name="drugscom">
{{Drugscominteract|quetiapine-with-topiramate|quetiapine|topiramate}}</ref>
}}